Log In
Print
BCIQ
Print
Print this Print this
 

Redectane, 124-Iodine-girentuximab (CA9-SCAN)

Also known as: WX-G250RIT

  Manage Alerts
Collapse Summary General Information
Company Wilex AG
DescriptionRadiolabeled WX-G250 antibody
Molecular Target Carbonic anhydrase IX (CAIX)
Mechanism of ActionDiagnostic; Radiolabelled antibody
Latest Stage of DevelopmentPhase III
IndicationCancer, Diagnostic
Partner

Ion Beam Applications S.A.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today